Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project

BACKGROUND: Pyrazinamide and fluoroquinolones are essential antituberculosis drugs in new rifampicin-sparing regimens. However, little information about the extent of resistance to these drugs at the population level is available. METHODS: In a molecular epidemiology analysis, we used population-bas...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Lancet Infect Dis
Κύριοι συγγραφείς: Zignol, Matteo, Dean, Anna S, Alikhanova, Natavan, Andres, Sönke, Cabibbe, Andrea Maurizio, Cirillo, Daniela Maria, Dadu, Andrei, Dreyer, Andries, Driesen, Michèle, Gilpin, Christopher, Hasan, Rumina, Hasan, Zahra, Hoffner, Sven, Husain, Ashaque, Hussain, Alamdar, Ismail, Nazir, Kamal, Mostofa, Mansjö, Mikael, Mvusi, Lindiwe, Niemann, Stefan, Omar, Shaheed V, Qadeer, Ejaz, Rigouts, Leen, Ruesch-Gerdes, Sabine, Schito, Marco, Seyfaddinova, Mehriban, Skrahina, Alena, Tahseen, Sabira, Wells, William A, Mukadi, Ya Diul, Kimerling, Michael, Floyd, Katherine, Weyer, Karin, Raviglione, Mario C
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Elsevier Science ;, The Lancet Pub. Group 2016
Θέματα:
Articles
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5030278/
https://ncbi.nlm.nih.gov/pubmed/27397590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(16)30190-6
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια